Venue: The Gibson Hotel, Point Village, Dublin 1, Ireland
08:00 Registration/Exhibition
08:40 Opening of the ISADD Symposium Dublin
(D. O’Keeffe, Ireland and K. van Tilburg, The Netherlands)
Chairman: K. van Tilburg, The Netherlands
08:45 A model of cerebrospinal fluid production and reabsorption driven by Starlin forces
(A. Linninger, USA)
09:10 Frequency and magnitude of cerebrospinal fluid pulsations influence intrathecal drug
distribution: key factors for interpatient variability (A. Linninger, USA)
09:35 Drug delivery systems for chronic non-malignant pain: past, present and future
directions (M. Hamza, USA)
10:00 Polyanalgesic regimens to decrease neuropathic – and nociceptive chronic pain
(S. Eldabe, UK)
10:25 Tea & Coffee Break/Exhibition
Chairman: J. Keaveny, Ireland
10:55 Trends and future needs for intrathecal chronic pain treatment (S. Hayek, USA)
11:20 Intrathecal magnetic drug targeting using gold-coated magnetite nanoparticles in a
human spine model (A. Linninger, USA)
11:45 Filing of consent decree from US FDA against ITDD company – how to proceed?
(D. O’Keeffe, Ireland)
12:10 Oral free presentation: Intrathecal Bupivacaine as an alternative to Intrathecal
Opioids for Failed Back Surgery Syndrome: A Case Study (M. Dugan, USA)
12:20 Oral free presentation: Intrathecal chronic morphine infusion pumps for intractable
cancer pain: a pilot series in Russia (O. Kirsanova, Russia)
12:30 Oral free presentation: Objective 4D-Measurements of Lumbar Spine Function in
Back Pain Patients Undergoing High-Frequency Spinal Cord Stimulation at 10 kHz
(R. Ibrahim, Germany)
12:40 Lunch/Exhibition
Chairman: D. O’Keeffe, Ireland
13:40 Long term experience and performance monitoring for a therapy designed to last
(C. Perruchoud, Switzerland)
14:05 Ziconotide and its stability in intrathecal analgesic mixtures (D. Dupoiron, France)
14:30 Types and modes of intrathecal analgesic drug delivery for cancer pain
(C. Perruchoud, Switzerland)
14:55 Tea & Coffee Break/Exhibition
Chairman: K. van Tilburg, The Netherlands
15:25 Cervical and intraventricular analgesic drug delivery for head and neck pain
(D. Dupoiron, France)
15:50 Cost effectiveness of intrathecal analgesic drug delivery (S. Hayek, USA)
16:15 Complications of intrathecal analgesic drug delivery (S. Eldabe, UK)
16:40 Oral free presentation: The role of the height of the intrathecal catheter and the
daily flow of a gas pump in the effectiveness of an intrathecal baclofen therapy
(A. Chatzikalfas, Germany)
16:50 Oral free presentation: Challenges of Spasticity Management Using Two Different
Intrathecal Drug Delivery Device Systems (IDDS) - Pinderfields Way!
(W. Raza, UK)
17:00 Consensus of ethical, clinical and legal standpoints (D. O’Keeffe, Ireland)
17:25 Closing Remarks (K. van Tilburg, The Netherlands)
17:30 Networking Reception
18:30 Symposium Dinner
